Abstract
Novel non-steroidal progesterone receptor antagonists with a 3-phenylquinazoline-2,4-dione/2-phenylisoquinoline-1,3-dione skeleton were developed and their structure-activity relationships were investigated. Among the prepared compounds, 4-(4,4-diethyl-3,4-dihydro-1,3-dioxoquinolin-2(1H)-yl)benzonitrile (DEPIQ-4CN) showed the most potent activity, with IC(50) values of 74-78nM in alkaline phosphatase activity and reporter gene assays.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alkaline Phosphatase
-
Animals
-
CHO Cells
-
Cell Line, Tumor
-
Cricetinae
-
Cricetulus
-
Genes, Reporter
-
Humans
-
Inhibitory Concentration 50
-
Quinazolines / chemistry
-
Quinazolines / pharmacology*
-
Quinolines / chemistry
-
Quinolines / pharmacology*
-
Receptors, Progesterone / antagonists & inhibitors*
-
Structure-Activity Relationship
Substances
-
Quinazolines
-
Quinolines
-
Receptors, Progesterone
-
Alkaline Phosphatase